Pre-clinical models
Probiotic pre-clinical models
Probiotic pre-clinical models are crucial for evaluating safety, efficacy, and mode of action of a probiotic strain before it can be tested in humans.
These models involve a variety of in vitro (test tube or culture dish) and in vivo (animal model) studies.
BioGaia’s Limosilactobacillus reuteri (formerly known as Lactobacillus reuteri) strains have been studied in pre-clinical models in more than 50 universities and microbiological institutions worldwide. These studies have contributed to knowledge regarding how to produce, package, and distribute our probiotic products. We have also gained information regarding in which areas our strains are likely to have a positive effect on human health, and hence, which areas it might be relevant to do clinical studies within. Finally, pre-clinical models can explain and strengthen the results we see in clinical trials.